NADH/NAD⁺ Ratio Probes Development Service
NADH/NAD⁺ redox balance is a key indicator of mitochondrial energy metabolism, oxidative phosphorylation, glycolytic activity, cellular redox state, metabolic stress, aging, and drug response. MitoGlowing™ provides a comprehensive NADH/NAD⁺ Ratio Probes Development Service to support custom fluorescent probe design, bioluminescent assay development, enzymatic cycling assay optimization, biological validation, and high-throughput workflow development for live-cell imaging, mitochondrial metabolism research, disease models, drug screening, and translational metabolic studies.
Introduction to NADH/NAD⁺ Ratio Probes
Nicotinamide adenine dinucleotide exists mainly in two interconvertible forms: oxidized NAD⁺ and reduced NADH. NAD⁺ functions as an electron acceptor, while NADH functions as an electron donor in major metabolic pathways such as glycolysis, the TCA cycle, and oxidative phosphorylation. The NADH/NAD⁺ ratio, or its reciprocal NAD⁺/NADH ratio depending on assay convention, provides important information about cellular energy status, mitochondrial respiration, metabolic reprogramming, and redox homeostasis.
For mitochondrial research, NADH/NAD⁺ ratio analysis is especially valuable because mitochondrial respiration continuously consumes NADH and regenerates NAD⁺ through electron transport chain activity. Changes in this ratio can reflect mitochondrial dysfunction, respiratory chain inhibition, hypoxia, metabolic adaptation, aging-related decline, cancer metabolism, drug-induced toxicity, and therapeutic response.
NADH/NAD⁺ ratio probe development may involve enzyme-coupled cycling, bioluminescent readouts, fluorogenic detection, near-infrared live-cell imaging, subcellular localization design, or high-content screening workflows. Depending on the research goal, probes and assays can be optimized for NADH detection, NAD⁺ detection, total NAD(H), NAD⁺/NADH ratio calculation, mitochondrial NADH imaging, or integrated energy metabolism profiling with ATP/ADP, ROS, membrane potential, calcium, and cell viability assays.
Fig.1 (a) Synthesis of MQN and (b) Reaction Mechanism of Probe MQN with NADH
Features of NADH/NAD⁺ Ratio Probes Development
- NADH/NAD⁺ redox-responsive assay design based on enzymatic cycling, bioluminescence, fluorogenic conversion, NADH-responsive fluorescence activation, ratiometric signal transformation, or near-infrared live-cell imaging.
- Mitochondria-focused metabolism probe engineering for mitochondrial NADH monitoring, respiratory chain activity analysis, metabolic stress evaluation, and organelle-specific energy metabolism studies.
- Quantitative ratio readout options for NADH, NAD⁺, total NAD(H), NADH/NAD⁺ ratio, NAD⁺/NADH ratio, and related NADP⁺/NADPH redox pair analysis.
- High-throughput screening compatibility for 96-well, 384-well, low-volume 384-well, and selected miniaturized plate workflows for compound screening and IC₅₀ determination.
- Live-cell and imaging compatibility through fluorescent or near-infrared NADH probes for live-cell imaging, confocal microscopy, high-content imaging, and selected tissue or disease model studies.
- Application-specific biological validation for cancer metabolism, NAMPT inhibitor screening, mitochondrial disease research, skin energy metabolism, aging studies, NAD⁺ precursor evaluation, exercise/nutrition research, and drug-induced metabolic toxicity.
Our Services
MitoGlowing™ provides an integrated NADH/NAD⁺ ratio probe development workflow covering assay strategy design, molecular probe development, photophysical characterization, biochemical validation, biological testing, and application-specific workflow optimization.
Project Design & Metabolic Readout Strategy
- Define the target application, such as mitochondrial metabolism analysis, cancer drug screening, mitochondrial disease research, aging-related redox evaluation, skin metabolism studies, or supplement efficacy testing.
- Select the preferred readout format, including fluorescence, bioluminescence, enzymatic cycling, NIR live-cell imaging, microplate assay, high-content imaging, or combined metabolic profiling.
- Determine whether the project requires NADH detection, NAD⁺ detection, total NAD(H), NADH/NAD⁺ ratio, reciprocal NAD⁺/NADH ratio, or related NADP⁺/NADPH redox pair analysis.
- Design validation strategies using metabolic inhibitors, respiratory chain modulators, NAMPT inhibitors, hypoxia/reoxygenation models, NAD⁺ precursors, oxidizing/reducing controls, and biological disease models.
Molecular Probe & Assay System Development
- Design NADH-responsive probes based on rhodamine, quinoline, cyanine, hemicyanine, BODIPY, naphthalimide, or near-infrared fluorophore scaffolds.
- Develop enzyme-coupled or bioluminescent assay workflows for NAD⁺, NADH, total NAD(H), and ratio calculation.
- Introduce mitochondrial targeting groups, solubility-enhancing groups, signal-amplification modules, or ratiometric readout designs when required.
- Optimize probe permeability, fluorescence background, reaction kinetics, photostability, aqueous compatibility, and biological compatibility.
- Support assay format development for cell lysates, live cells, tissues, whole blood, plasma, serum, or high-throughput screening plates.
Photophysical & Biochemical Characterization
- Measure absorption spectra, emission spectra, excitation/emission maxima, Stokes shift, fluorescence intensity, quantum yield, luminescence intensity, and signal stability.
- Evaluate response kinetics, linear detection range, detection limit, signal-to-background ratio, assay window, and reproducibility.
- Compare response toward NADH, NAD⁺, NADPH, NADP⁺, flavins, thiols, ROS, reducing agents, oxidizing agents, metal ions, and biological matrix components.
- Assess pH stability, buffer compatibility, serum tolerance, solvent tolerance, storage stability, and plate-reader compatibility.
- Characterize near-infrared emission, live-cell imaging performance, mitochondrial localization, or high-content imaging suitability when required.
Biological Validation & Assay Development
- Validate cell permeability, intracellular retention, mitochondrial localization, and compatibility with live-cell imaging or cell lysate workflows.
- Optimize sample extraction, acid/base treatment, enzyme cycling conditions, staining concentration, incubation time, plate format, and readout timing.
- Test probe or assay response in metabolic perturbation models, such as NAMPT inhibition, ETC inhibition, glycolysis modulation, oxidative stress, hypoxia/reoxygenation, or NAD⁺ precursor treatment.
- Develop workflows for fluorescence microscopy, confocal imaging, microplate readers, luminescence readers, flow cytometry, high-content imaging, and selected tissue or animal model platforms.
- Establish quantitative analysis methods, including standard curve generation, RLU or fluorescence intensity calculation, NADH/NAD⁺ ratio calculation, dose-response curves, IC₅₀ determination, and time-course monitoring.
Supported Sample Types and Models
- Cancer cell lines, tumor spheroids, organoids, and cancer metabolism models
- Mitochondrial dysfunction and respiratory chain inhibition models
- Drug-treated, hypoxia/reoxygenation-treated, oxidative stress-treated, nutrient-stressed, or supplement-treated cells
- Cardiomyocyte and cardiotoxicity models, including H9C2 cells, primary cardiomyocytes, and iPSC-derived cardiomyocytes
- Neuronal and neurodegenerative disease models, including PC12 cells, SH-SY5Y cells, primary neurons, and brain tissue models
- Other customized biological or analytical models upon request
- Hepatocytes, liver injury models, metabolic syndrome models, and fatty liver-related models
- Skin fibroblasts, keratinocytes, UV/oxidative stress skin aging models, and cosmetic efficacy models
- NAMPT, CD38, PARP, sirtuin, and NAD⁺ salvage pathway-related models
- Plasma, serum, whole blood, tissue extracts, cell lysates, and selected biological fluids
- 96-well, 384-well, low-volume 384-well, and selected high-throughput assay formats
Application
Cancer Drug Development and NAMPT Inhibitor Screening
NADH/NAD⁺ ratio assays are valuable for evaluating metabolic vulnerabilities in cancer drug development. NAMPT is a key enzyme in the NAD⁺ salvage pathway, and NAMPT inhibition can deplete cellular NAD pools, disrupt energy metabolism, increase oxidative stress susceptibility, and reduce cancer cell viability.
This application supports the development of NADH/NAD⁺ probe and assay workflows for NAMPT inhibitor screening, IC₅₀ determination, cancer cell metabolic profiling, drug resistance studies, and early-stage anticancer drug discovery.
Mitochondrial Disease and Redox Diagnostic Research
NADH/NAD⁺ and related NADP⁺/NADPH redox assays can support mitochondrial disease research by linking redox imbalance to electron transport chain dysfunction. Patient-derived cell models, such as fibroblasts, can be used to evaluate respiratory chain activity and mitochondrial redox stress.
This application supports NADH/NAD⁺ and NAD(P)H/NAD(P)⁺ probe development for mitochondrial respiratory chain evaluation, rare disease studies, Leigh syndrome-related research, neuroinflammation mechanisms, and drug development for inherited metabolic disorders.
Skin Metabolism and Cosmetic Anti-Aging Research
NADH/NAD⁺ balance can be used to evaluate cellular energy metabolism in skin models. Fibroblast or keratinocyte systems, oxidative stress models, and ingredient-treated skin cell assays can help assess whether anti-aging formulations modulate NAD⁺ balance and metabolic recovery.
This application supports probe and assay development for skin fibroblast metabolism, UV-induced oxidative stress models, anti-aging ingredient validation, cosmetic efficacy testing, and molecular mechanism studies for NAD⁺-related skin health claims.
Supplement, Sports Nutrition, and Whole-Blood NAD Testing
NADH/NAD⁺ ratio assays can support evaluation of NAD⁺ precursors, metabolic health interventions, exercise nutrition, and personalized health research. Whole-blood or biological fluid workflows can be adapted for longitudinal monitoring of NAD⁺ and NADH changes after supplementation or lifestyle intervention.
This application supports NADH/NAD⁺ assay development for NAD⁺ precursor evaluation, NR/NMN-related supplement research, exercise metabolism studies, blood-based metabolic monitoring, and health management biomarker development.
Technology Comparison Summary
| Application Area | Representative Method | Core Value | Development Focus |
|---|---|---|---|
| Cancer drug development | Bioluminescent NAD/NADH-Glo assay | High-throughput NAMPT inhibitor and NAD⁺ metabolism screening | 96/384/1536-well compatibility, IC₅₀ curves, reproducibility |
| Mitochondrial disease research | NADH/NAD⁺ and NADP⁺/NADPH redox assays | Mitochondrial respiratory chain and redox dysfunction evaluation | Patient-derived cells, fibroblasts, respiratory chain models |
| Skin and cosmetic research | Fluorescence or microplate NAD⁺/NADH assays | Skin energy metabolism and anti-aging efficacy validation | Fibroblast models, UV/oxidative stress, ingredient response |
| Supplement and sports nutrition | Whole-blood NAD⁺/NADH assay kits | NAD⁺ precursor and metabolic health evaluation | Blood sample workflows, ratio calculation, longitudinal monitoring |
| Live-cell metabolic imaging | NIR NADH fluorescent probes | Dynamic NADH visualization in living cells | Mitochondrial targeting, low background, real-time imaging |
Our Advantages
- Integrated metabolism probe and assay development: We combine molecular probe design, enzymatic assay engineering, photophysical characterization, biochemical validation, and biological assay optimization to generate NADH/NAD⁺ workflows that are both sensitive and biologically meaningful.
- Mitochondria-focused energy metabolism expertise: Our platform supports NADH/NAD⁺ ratio probe development for oxidative phosphorylation, electron transport chain dysfunction, metabolic reprogramming, hypoxia, aging, and mitochondrial disease models.
- Flexible detection strategy: We support fluorescence, near-infrared imaging, bioluminescence, enzymatic cycling, microplate detection, live-cell imaging, and high-content screening formats according to the project goal.
- High-throughput and translational assay compatibility: Probe and assay workflows can be optimized for drug discovery, NAMPT inhibitor screening, supplement evaluation, whole-blood testing, cell lysate assays, and tissue-based metabolic studies.
- Multi-parameter mitochondrial profiling: NADH/NAD⁺ ratio analysis can be integrated with ATP/ADP, ROS, membrane potential, calcium, oxygen consumption, glycolysis, apoptosis, cell viability, and mitochondrial morphology assays to build a complete mitochondrial energy metabolism profile.
Contact Us
Develop sensitive, quantitative, and application-specific NADH/NAD⁺ ratio probes with Protheragen's NADH/NAD⁺ Ratio Probes Development Service. Contact us with your target model, preferred detection platform, sample type, throughput requirement, mitochondrial localization need, and research objective. Our team will recommend a tailored probe or assay development strategy for mitochondrial metabolism analysis, cancer drug screening, mitochondrial disease research, skin metabolism studies, supplement evaluation, and translational metabolic profiling.
Reference
1. Podder, A., Murali, V. P., Deepika, S., Dhamija, A., Biswas, S., Maiti, K. K., & Bhuniya, S. (2020). NADH-Activated Dual-Channel Fluorescent Probes for Multicolor Labeling of Live Cells and Tumor Mimic Spheroids. Analytical chemistry, 92(18), 12356–12362.
